Skip to content
Discover the latest urban lifestyle trends, culture, and ci…

Users Coming Off Slimming Medications Gain Back Pounds at a Quadrupled Rate Than Those on Conventional Diets

Illustration of medical syringe and scale
Obesity treatment involves ongoing approaches.

A recent study reveals that patients who discontinue popular slimming jabs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who end conventional diet and exercise regimens.

Findings released in a prominent health publication shows that while overweight individuals can lose about a fifth of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing these drugs must be informed of the danger of rapid weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.

This pace of regain suggests a return to pre-treatment weight within about 18 months.

Comparing Approaches

The research, which reviewed 37 of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with older methods.

The team note that people who shed pounds through diet and exercise typically experience a less rapid creep back—approximately 0.1 kg a month—once they finish.

Explaining the Quick Rebound

Doctors believe the way of the jabs explains the heightened regain.

These medications copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Sustained high doses of the hormone concentrations several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication means appetite is no longer kept in check, making overeating a significant risk."

A Chronic Disease?

Health authorities recommend the injections for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.

A number of clinicians contend that, given the high risk of weight regain, the treatment is often ongoing.

This view is reinforced by pharmaceutical companies, who state that the results "underscore the long-term nature of excess weight," comparing it to managing conditions like high blood pressure.

Patient Testimonies

Users who have discontinued the jabs report a powerful resurgence of cravings.

"It was like a switch flipping and you become ravenous," recalled an individual.

The struggle is exacerbated if patients have not adopted permanent lifestyle or habit modifications during therapy.

Widespread Interest

Survey data suggest that millions of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow.

  • Use is greater among females than males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion access the drugs through private healthcare rather than the NHS.

Ultimately, researchers stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent cure and long-term success hinges on combined behavioural management.

TS
The writer

Taylor Simpson

Eleanor is a seasoned urban lifestyle writer with a passion for uncovering hidden city gems.

UrbanMegaReview UK

Type to search articles.